These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. Suzuki A; Sanda N; Miyawaki Y; Fujimori Y; Yamada T; Takagi A; Murate T; Saito H; Kojima T J Biol Chem; 2010 Apr; 285(18):13444-53. PubMed ID: 20200160 [TBL] [Abstract][Full Text] [Related]
7. Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells. Zhang XL; Zhang D; Michel FJ; Blum JL; Simmen FA; Simmen RC J Biol Chem; 2003 Jun; 278(24):21474-82. PubMed ID: 12672823 [TBL] [Abstract][Full Text] [Related]
8. Ligand activated hPR modulates the glycodelin promoter activity through the Sp1 sites in human endometrial adenocarcinoma cells. Gao J; Mazella J; Seppala M; Tseng L Mol Cell Endocrinol; 2001 May; 176(1-2):97-102. PubMed ID: 11369448 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells. Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542 [TBL] [Abstract][Full Text] [Related]
10. GC-rich promoter elements maximally confers estrogen-induced transactivation of LRP16 gene through ERalpha/Sp1 interaction in MCF-7 cells. Han WD; Si YL; Zhao YL; Li Q; Wu ZQ; Hao HJ; Song HJ J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):47-56. PubMed ID: 18206366 [TBL] [Abstract][Full Text] [Related]
11. Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-monophosphate but not estradiol. Clemens JW; Robker RL; Kraus WL; Katzenellenbogen BS; Richards JS Mol Endocrinol; 1998 Aug; 12(8):1201-14. PubMed ID: 9717846 [TBL] [Abstract][Full Text] [Related]
12. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes. Diep CH; Ahrendt H; Lange CA Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites. Petz LN; Ziegler YS; Schultz JR; Kim H; Kemper JK; Nardulli AM J Steroid Biochem Mol Biol; 2004 Feb; 88(2):113-22. PubMed ID: 15084343 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641 [TBL] [Abstract][Full Text] [Related]
15. The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells. Bryant W; Snowhite AE; Rice LW; Shupnik MA Endocrinology; 2005 Feb; 146(2):751-9. PubMed ID: 15528307 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells. Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777 [TBL] [Abstract][Full Text] [Related]
18. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Kim K; Thu N; Saville B; Safe S Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites. Wietzke JA; Ward EC; Schneider J; Welsh J Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452 [TBL] [Abstract][Full Text] [Related]
20. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism. Shatnawi A; Tran T; Ratnam M Mol Endocrinol; 2007 Mar; 21(3):635-50. PubMed ID: 17192405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]